In the present study, we used targeted next-generation sequencing for mutation analysis of primary tumor tissues from 50 patients metastatic RCC, and we detected Nrf2 gene mutation in 5 patients, Keap1 gene mutation in 11 patients, and VHL gene mutation in 35 patients. Here, KEAP1 is linked to renal cell carcinoma.